학술논문
Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial
Document Type
Article
Author
Source
In: Clinical Infectious Diseases . (Clinical Infectious Diseases, 1 October 2023, 77(7):1012-1020)
Subject
Language
English
ISSN
15376591
10584838
10584838